ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 271 filers reported holding ALKERMES PLC in Q3 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,199,000 | -59.3% | 815,016 | -45.7% | 0.12% | -53.1% |
| Q2 2022 | $44,685,000 | +13.2% | 1,500,000 | 0.0% | 0.25% | +11.9% |
| Q1 2022 | $39,465,000 | +13.1% | 1,500,000 | 0.0% | 0.23% | +33.5% |
| Q4 2021 | $34,890,000 | -7.9% | 1,500,000 | +22.1% | 0.17% | +2.4% |
| Q3 2021 | $37,877,000 | +25.8% | 1,228,170 | 0.0% | 0.17% | +25.8% |
| Q2 2021 | $30,115,000 | +31.3% | 1,228,170 | 0.0% | 0.13% | +33.3% |
| Q1 2021 | $22,942,000 | -25.1% | 1,228,170 | -20.0% | 0.10% | -13.9% |
| Q4 2020 | $30,626,000 | +36.0% | 1,535,149 | +13.0% | 0.12% | +27.8% |
| Q3 2020 | $22,519,000 | -6.8% | 1,359,001 | +9.2% | 0.09% | -15.9% |
| Q2 2020 | $24,154,000 | +34.6% | 1,244,744 | 0.0% | 0.11% | -3.6% |
| Q1 2020 | $17,949,000 | +10.9% | 1,244,744 | +56.9% | 0.11% | +29.1% |
| Q4 2019 | $16,180,000 | +32.7% | 793,130 | +26.9% | 0.09% | +3.6% |
| Q3 2019 | $12,194,000 | +35.2% | 625,030 | +56.3% | 0.08% | +36.1% |
| Q2 2019 | $9,016,000 | +268.8% | 400,000 | +497.0% | 0.06% | +281.2% |
| Q1 2019 | $2,445,000 | +23.7% | 67,000 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $1,977,000 | -53.5% | 67,000 | -33.2% | 0.02% | -42.9% |
| Q3 2018 | $4,255,000 | +3.1% | 100,251 | 0.0% | 0.03% | -9.7% |
| Q2 2018 | $4,126,000 | -29.0% | 100,251 | 0.0% | 0.03% | -36.7% |
| Q1 2018 | $5,811,000 | -29.3% | 100,251 | -33.3% | 0.05% | -31.0% |
| Q4 2017 | $8,223,000 | +7.6% | 150,251 | 0.0% | 0.07% | +14.5% |
| Q3 2017 | $7,639,000 | -12.3% | 150,251 | 0.0% | 0.06% | -18.4% |
| Q2 2017 | $8,710,000 | -0.9% | 150,251 | 0.0% | 0.08% | +5.6% |
| Q1 2017 | $8,790,000 | +5.3% | 150,251 | 0.0% | 0.07% | -12.2% |
| Q4 2016 | $8,351,000 | -29.0% | 150,251 | -40.0% | 0.08% | -23.4% |
| Q3 2016 | $11,769,000 | +8.8% | 250,251 | 0.0% | 0.11% | -5.3% |
| Q2 2016 | $10,816,000 | +26.4% | 250,251 | 0.0% | 0.11% | +25.6% |
| Q1 2016 | $8,556,000 | -56.9% | 250,251 | 0.0% | 0.09% | -45.5% |
| Q4 2015 | $19,865,000 | – | 250,251 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 8,964,640 | $234,246,043 | 27.88% |
| Krensavage Asset Management, LLC | 1,401,783 | $36,629 | 11.32% |
| Hardman Johnston Global Advisors LLC | 5,561,806 | $145,329,991 | 5.69% |
| 13D Management LLC | 383,584 | $10,023,050 | 5.27% |
| Prosight Management, LP | 341,521 | $8,923,944 | 4.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $15,483,230 | 4.78% |
| Tamarack Advisers, LP | 275,000 | $7,185,750 | 3.70% |
| Ally Bridge Group (NY) LLC | 142,002 | $3,710,512 | 3.61% |
| HealthCor Management, L.P. | 110,000 | $2,874,300 | 2.63% |
| Price Jennifer C. | 360,600 | $9,422,478 | 2.25% |